Nicotinamide and 1-methylnicotinamide reduce homocysteine neurotoxicity in primary cultures of rat cerebellar granule cells

Acta Neurobiologiae Experimentalis

Volumn 68, Issue 1, 2008, Pages 1-9

  Slomka, Marta ^a   Zieminska, Elzbieta ^a   Lazarewicz, Jerzy W ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

1 methylnicotinamide; Cerebellar granule cells; Excitotoxicity; Homocysteine; Neuroprotection; Nicotinamide

Indexed keywords

1 METHYLNICOTINAMIDE; HOMOCYSTEINE; NICOTINAMIDE;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXCITOTOXICITY; GRANULE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CELL COUNT; CELLS, CULTURED; CEREBELLUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HOMOCYSTEINE; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NIACINAMIDE; RATS;

EID: 41749101585     PISSN: 00651400     EISSN: 00651400     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15: 961-973.
2. Baydas G, Reiter RJ, Akbulut M, Tuzcu M, Tamer S (2005) Melatonin inhibits neural apoptosis induced by homocysteine in hippocampus of rats via inhibition of cytochrome c translocation and caspase-3 activation and by regulating pro- and anti-apoptotic protein levels. Neuroscience 335: 879-886.
3. Bedalov A, Simon JA (2004) Neuroscience. NAD to the rescue. Science 305: 954-955.
4. Choi DW (1985) Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58: 293-297.
5. Chong ZZ, Lin SH, Maiese K (2002) Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury. J Vasc Res 39: 131-147.
6. Chong ZZ, Lin SH, Maiese K (2004) The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential. J Cereb Blood Flow Metab 24: 728-743.
7. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55: 1449-1455.
8. Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP (2002) Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J Neurochem 80: 101-110.
9. Feng Y, Paul IA, LeBlanc MH (2006) Nicotinamide reduces hypoxic ischemic brain injury in the newborn rat. Brain Res Bull 69: 117-122.
10. Frantseva MV, Carlen PL, Perez Velazquez JL (2001) Dynamics of intracellular calcium and free radical production during ischemia in pyramidal neurons. Free Radic Biol Med 31: 1216-12327.
11. Fujimura M, Tominaga T, Yoshimoto T (1997) Nicotinamide inhibits inducible nitric oxide synthase mRNA in primary rat glial cells. Neurosci Lett. 228: 107-110.
12. Fukushima T, Tawara T, Isobe A, Hojo N, Shiwaku K, Yumane Y (1995) Radical formation site of cerebral complex 1 and Parkinson's disease. J Neurosci Res 42: 385-390.
13. Fukushima T, Kaetsu A, Lim H, Moriyama M (2002) Possible role of 1-methylnicotinamide in the pathogenesis of Parkinson's disease. Exp Toxic Pathol 53: 469-473.
14. Fuso A, Seminara L, Cavallaro RA, D'Anselmi F, Scarpa S (2005) S-adenosylmethionine/ homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci 28: 195-204.
15. Gallo V, Suergiu R, Giovannini C, Levi G (1987) Glutamate receptor subtypes in cultured cerebellar neurons: modulation of glutamate and gamma-aminobutyric acid release. J Neurochem 49: 1801-1809.
16. Gebicki J, Sysa-Jedrzejowska A, Adamus J, Wozniacka A, Rybak M, Zielonka J (2003) 1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin. Pol J Pharmacol 55: 109-112.
17. Gonzalez-Polo RA, Soler G, Fuentes JM (2004) MPP+: mechanism for its toxicity in cerebellar granule cells. Mol Neurobiol 30: 253-264.
18. Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354: 407-413.
19. Kim WK, Pae YS (1996) Involvement of N-methyl-D-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture. Neurosci Lett 216: 117-120.
20. Klaidman LK, Mukherjee SK, Adams JD Jr (2001) Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide. Biochim Biophys Acta 1525: 136-148.
21. Kristal BS, Dubinsky JM (1997) Mitochondrial permeability transition in the central nervous system: induction by calcium cycling-dependent and -independent pathways. J Neurochem 69: 524-538.
22. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20: 6920-6926.
23. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22: 1752-1762.
24. Lee EJ, Wu TS, Chang GL, Li CY, Chen TY, Lee MY, Chen HY, Maynard KI (2006) Delayed treatment with nicotinamide inhibits brain energy depletion, improves cerebral microperfusion, reduces brain infarct volume, but does not alter neurobehavioral outcome following permanent focal cerebral ischemia in Sprague Dawley rats. Curr Neurovasc Res 3: 203-213.
25. Li F, Chong ZZ, Maiese K (2004) Navigating novel mechanisms of cellular plasticity with the NAD+ precursor and nutrient nicotinamide. Front Biosci. 9: 2500-2520.
26. Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV, Arnelle DR, Stamler JS (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 94: 5923-5928.
27. Luchowska E, Luchowski P, Paczek R, Ziembowicz A, Kocki T, Turski WA, Wielosz M, Lazarewicz J, Urbanska EM (2005) Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid. J Neurosci Res 79: 375-382.
28. Maiese K, Chong ZZ (2003) Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol Sci 24: 228-232.
29. Marini AM, Ueda Y, June CH (1999) Intracellular survival pathways against glutamate receptor agonist excitotoxicity in cultured neurons. Intracellular calcium responses. Ann N Y Acad Sci 890: 421-437.
30. Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26: 137-146.
31. Mokudai T, Ayoub IA, Sakakibara Y, Lee EJ, Ogilvy CS, Maynard KI (2000) Delayed treatment with nicotinamide (Vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats. Stroke 31: 1679-1685.
32. Morris MS (2003) Homocysteine and Alzheimer's disease. Lancet Neurol 2: 425-428.
33. Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 36: 2503-2508.
34. Obeid R, Herrmann W (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580: 2994-3005.
35. Obeid R, Kasoha M, Knapp JP, Kostopoulos P, Becker G, Fassbender K, Herrmann W (2007) Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid. Clin Chem 53: 1129-1136.
36. Ogata S, Takeuchi M, Fujita H, Shibata K, Okumura K, Taguchi H (2000) Apoptosis induced by nicotinamide-related compounds and quinolinic acid in HL-60 cells. Biosci Biotechnol Biochem 64: 327-332.
37. Parsons RB, Smith ML, Williams AC, Waring RH, Ramsden DB (2002) Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain. J Neuropathol Exp Neurol 61: 111-124.
38. Schousboe A, Drejer J, Hansen GH, Meier E (1985) Cultured neurons as model systems for biochemical and pharmacological studies on receptors for neurotransmitter amino acids. Dev Neurosci 7: 252-262.
39. Selhub J, Miller JW (1992) The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 55: 131-138.
40. Selhub J (1999) Homocysteine metabolism. Ann Rev Nutr 19: 217-246.
41. Shen CC, Huang HM, Ou HC, Chen HL, Chen WC, Jeng KC (2004) Protective effect of nicotinamide on neuronal cells under oxygen and glucose deprivation and hypoxia/reoxygenation. J Biomed Sci 11: 472-481.
42. Sontag E, Nunbhakdi-Craig V, Sontag JM, Diaz-Arrastia R, Ogris E, Dayal S, Lentz SR, Arning E, Bottiglieri T (2007) Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J Neurosc. 27: 2751-2759.
43. Stazka J, Luchowski P, Urbanska EM (2005) Homocysteine, a risk factor for atherosclerosis, biphasically changes the endothelial production of kynurenic acid. Eur J Pharmacol. 517: 217-223.
44. Tam D, Tam M, Maynard KI (2005) Nicotinamide modulates energy utilization and improves functional recovery from ischemia in the in vitro rabbit retina. Ann N Y Acad Sci 1053: 258-268.
45. Ungerstedt JS, Blomback M, Soderstrom T (2003) Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol 131: 48-52.
46. Urbanska EM, Luchowski P, Luchowska E, Pniewski J, Wozniak R, Chodakowska-Zebrowska M, Lazarewicz J (2006) Serum kynurenic acid positively correlates with cardiovascular disease risk factor, homocysteine: a study in stroke patients. Pharmacol Rep 58: 507-511.
47. Williams A, Ramsden D (2005) Nicotinamide: A double adged sword. Parkinsonism Relat Disord 11: 413-420.
48. Williams AC, Cartwright LS, Ramsden DB (2005) Parkinson's disease: the first common neurological disease due to auto-intoxication? QJM 98: 215-226.
49. Yudkoff M (1999) Diseases of amino acid metabolism. In: Basic Neurochemistry; Molecular, Cellular and Medical Aspects (Siegel GJ, ed.). Lippincott Williams & Wilkins, a Wolters Kluwer Company, p. 887-915.
50. Zieminska E, Stafiej A, Lazarewicz JW (2003) Role of group I metabotropic glutamate receptors and NMDA receptors in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurones. Neurochem Int 43: 481-492.
51. Zieminska E, Lazarewicz JW (2006) Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group 1 metabotropic glutamate receptors. Acta Neurobiol Exp (Wars) 66: 301-309.
52. Zieminska E, Matyja E, Kozlowska H, Stafiej A, Lazarewicz JW (2006) Excitotoxic neuronal injury in acute homocysteine neurotoxicity: role of calcium and mitochondrial alterations. Neurochem Int 48: 491-497.